Refine
Year of publication
Document Type
- Doctoral Thesis (114) (remove)
Language
- English (114) (remove)
Keywords
- Adipositas (6)
- type 2 diabetes (6)
- obesity (5)
- Alterung (3)
- Proteom (3)
- aging (3)
- probiotics (3)
- protein (3)
- Bilophila wadsworthia (2)
- Biomarker (2)
- Carotinoide (2)
- Diabetes (2)
- Epidemiologie (2)
- Ernährung (2)
- FGF21 (2)
- Fettgewebe (2)
- HepG2 (2)
- Insulinresistenz (2)
- Kaffee (2)
- Mitochondrien (2)
- Nahrungssulfonate (2)
- Obesity (2)
- Selen (2)
- Stoffwechsel (2)
- Typ-2-Diabetes (2)
- Vollkorn (2)
- adipose tissue (2)
- carotenoids (2)
- chronisch-entzündliche Darmerkrankungen (2)
- coffee (2)
- cytokines (2)
- gut microbiota (2)
- inflammation (2)
- insulin resistance (2)
- metabolism (2)
- metabolomics (2)
- nutrition (2)
- odd chain fatty acids (2)
- protein modification (2)
- proteome (2)
- red meat (2)
- rotes Fleisch (2)
- selenium (2)
- ungeradkettige Fettsäuren (2)
- 3-Methylhistidin (1)
- 3-methylhistidine (1)
- 3D breast cell model (1)
- Adipose tissue (1)
- Adipozyt (1)
- Ageing (1)
- Akkermansia muciniphila (1)
- Aktivkohle (1)
- Alkoholkonsum (1)
- Alternative to animal testing (1)
- Antibeschlag-Additive (1)
- Antibiotikaresistenz (1)
- Arabica Kaffeebohnen (1)
- Arabica coffee beans (1)
- Assay High-resolution mass spectrometry (1)
- Assay hochauflösende Massenspektrometrie (1)
- Astrozyten (1)
- Ausdauerleistung (1)
- Autophagie Lysosomale System (1)
- BMI (1)
- Beer (1)
- Benzylisothiocyanat (1)
- Beta-Zelle (1)
- Bioaktivität (1)
- Blut-Hirn-Schranke (1)
- Body-Mass-Index (1)
- Botulinum neurotoxin (1)
- Botulinumtoxine (1)
- Breast cancer (1)
- Brustkrebs (1)
- CRISPR/Cas9 (1)
- CVD (1)
- Caco-2 (1)
- Caenorhabditis elegans (1)
- Cell proliferation (1)
- Cereals (1)
- Chemerin (1)
- Chlorogensäure (1)
- DNA methylation (1)
- Darmbakterien (1)
- Darmlänge (1)
- Diabetes mellitus Typ 2 (1)
- Dietary sulfonates (1)
- Differential Gene Expression (1)
- Differenzierung (1)
- Diät (1)
- E. coli (1)
- ENaC (1)
- Electrochemistry (1)
- Elektrochemie (1)
- Energiehaushalt (1)
- Enterolignanen (1)
- Enterolignans (1)
- Entzündung (1)
- Ernährungsfaktoren (1)
- Ernährungsmuster (1)
- Escherichia coli (1)
- FOXO1 (1)
- Fettstoffwechsel (1)
- Fettsäuren (1)
- Fettzelle (1)
- Flavonoide (1)
- Folientunnel (1)
- Food Chain (1)
- Frailty (1)
- GDF15 (1)
- GOAT (1)
- Gene Array (1)
- Gene Chip (1)
- Genetics (1)
- Genetik (1)
- Genexpression (1)
- Gewichtsverlust (1)
- Ghrelin (1)
- Glucagon (1)
- Glucose intolerance (1)
- Glukoseintoleranz (1)
- Glukosinolaten (1)
- HAMP (1)
- Halophyten (1)
- Hepatotoxizität (1)
- Herzinfarkt (1)
- Herzkreislauferkrankungen (1)
- Hungerhormon (1)
- IBD (1)
- IGF-1 (1)
- Immunhistochemie (1)
- Indoor farming (1)
- Induced pluripotent stem cells (1)
- Inflammatory bowel disease (1)
- Insulin (1)
- Insulin resistance (1)
- Insulin secretion (1)
- Insulin-induzierte Hypoglykämie (1)
- Insulinsekretion (1)
- Ivy (1)
- Kachexie (1)
- Kaffeenebenprodukte (1)
- Kaffeeproteine (1)
- Kaffeeverarbeitung (1)
- Kalzium (1)
- Kolokalisation (1)
- Kopfsalat (1)
- Kunststoff-Additive (1)
- Kupfer (1)
- Kurzkettige Fettsäuren (1)
- Körpergewichsterhalt (1)
- Körpergewichtsverlust (1)
- LC-MS/MS (1)
- Labormäuse (1)
- Lebensmittelkette (1)
- Lebensstil (1)
- Leber (1)
- Lignan-converting bacteria (1)
- Lignan-umwandelnde Bakterien (1)
- Lipidomics (1)
- Lipidstoffwechsel (1)
- MCHR-1 (1)
- MRSA (1)
- Makrophagen (1)
- Mangan (1)
- Massenspektrometrie (1)
- Mediationsanalyse (1)
- Metabolom (1)
- Metabolomics (1)
- MicroRNAs (1)
- Microarray (1)
- Microsomal (1)
- Mikrobiologie (1)
- Mikrobiota (1)
- Mikronährstoffe (1)
- Mikrosomal (1)
- Milcheinnahme (1)
- Mitochondria (1)
- Model (1)
- Modell (1)
- Molkenproteine (1)
- Motor neurons (1)
- Motorneurone (1)
- Multi-Methods (1)
- Muskelproteinumsatz (1)
- Mycotoxins (1)
- Nachkommen (1)
- Nahrung der Zukunft (1)
- Nahrungsfette (1)
- Nephropathie (1)
- Netzwerke (1)
- Neuronen (1)
- Neuropathie (1)
- Neuropeptides (1)
- Nährstoffe (1)
- OxyR (1)
- PBCEC (1)
- PRM/Alf Maus (1)
- PRM/Alf mouse (1)
- PUFA (1)
- PXR (1)
- Pannexin 1 (1)
- Pflanzliches Lignan (1)
- Phenole (1)
- Physiologie (1)
- Plant lignan (1)
- Polyamine (1)
- Preadipozyt (1)
- Pregnane X Receptor (1)
- Probiotika (1)
- Protein (1)
- Protein Modifizierung (1)
- Protein-Wechselwirkungen (1)
- Proteinmodifizierung (1)
- Proteostase (1)
- RBP (1)
- RNA Sequencing (1)
- RNA Sequenzierung (1)
- RNAseq (1)
- Ratte (1)
- Rauchen (1)
- Refinement (1)
- Resistance (1)
- Retinol-Bindungsprotein 4 (1)
- Retinol-binding protein 4 (1)
- Retinopathie (1)
- Risikobewertungen (1)
- SFA (1)
- Saline Landwirtschaft (1)
- Salzgeschmack (1)
- Schlaganfall (1)
- Selenonein (1)
- Skelettmuskel (1)
- Skelettmuskelalterung (1)
- Spurenelement (1)
- Stoffwechselkäfig (1)
- Styrol (1)
- Sulfid (1)
- Susceptibility-genes (1)
- Suszeptibilitätsgene (1)
- Säugetiere ; Fettgewebe ; Zelldifferenzierung ; Genexpression (1)
- Tierarzneimittel (1)
- Tierschutz (1)
- Tocopherol (1)
- Tocotrienol (1)
- Trans-Fettsäuren (1)
- Transformation product (1)
- Transformationsprodukt (1)
- Transkriptom (1)
- Transmission (1)
- Typ 2 Diabetes (1)
- Typ-2-Diabetes mellitus (1)
- Ubiquitin Proteasom System (1)
- VOC (1)
- Veterinary drugs (1)
- Vitamin A (1)
- Vitamin E (1)
- Vitamin K (1)
- Zellkulturen (1)
- Zellproliferation (1)
- Zink (1)
- activated carbon (1)
- acute inflammation (1)
- adipocyte (1)
- akute Entzündung (1)
- alcohol intake (1)
- alternative zu Tierversuchen (1)
- animal welfare (1)
- antifogging additives (1)
- apoptosis (1)
- astrocytes (1)
- autophagy lysosomal system (1)
- benzylisothiocyanate (1)
- beta-cell (1)
- bioactivity (1)
- biomarker (1)
- blood-brain barrier (1)
- body weight loss (1)
- body weight maintenance (1)
- branched chain amino acids (1)
- braunes Fettgewebe (1)
- brown adipose tissue (1)
- c-Fos (1)
- cachexia (1)
- calcium (1)
- cancer cachexia (1)
- caquexia (1)
- cell cuture (1)
- chemokines (1)
- chlorbenzol (1)
- chlorogenic acid (1)
- chronic and acute inflammation (1)
- coffee by-products (1)
- coffee processing (1)
- coffee proteins (1)
- colocalisation study (1)
- commensal (1)
- copper (1)
- dairy intake (1)
- depression (1)
- diabetes (1)
- dichlorbenzol (1)
- dichlorobenzene (1)
- diet (1)
- dietary antioxidants (1)
- dietary factors (1)
- dietary lipids (1)
- dietary sulfonates (1)
- differentiation (1)
- diätetische Antioxidantien (1)
- emotionality (1)
- endocrine disruption (1)
- energy homeostasis (1)
- epidemiology (1)
- epigenetics (1)
- exercise performance (1)
- fatty acids (1)
- fatty liver (1)
- flavonoids (1)
- frailty (1)
- future food (1)
- fígado (1)
- gene expression (1)
- geschützter Anbau (1)
- glucagon (1)
- glucosinolates (1)
- goblet cells (1)
- grafische Modelle (1)
- graphical models (1)
- gut length (1)
- halophytes (1)
- hepatotoxicity (1)
- high protein diet (1)
- human diet (1)
- hunger hormone (1)
- hypoxic pulmonary vasoconstriction (1)
- hypoxische pulmonale Vasokonstriktion (1)
- immune response (1)
- immunohistochemistry (1)
- indoor farming (1)
- induzierte pluripotente Stammzellen (1)
- infection (1)
- inflamação (1)
- inflammatory bowel disease (1)
- insulin (1)
- insulin-induced hypoglycemia (1)
- insulina (1)
- intestinal (1)
- intestinal inflammation (1)
- körperliche Aktivität (1)
- laboratory mice (1)
- lactobacillus (1)
- langsame und schnelle Fasertypen (1)
- lettuce (1)
- lifestyle (1)
- lipid metabolism (1)
- lipidomics (1)
- liver (1)
- macrophages (1)
- macrovascular complications (1)
- macrófagos (1)
- makrovaskuläre Komplikationen (1)
- manganese (1)
- mass spectrometry (1)
- maternal diet (1)
- maternale Ernährung (1)
- mediation analysis (1)
- menschliche Ernährung (1)
- metabolic cage (1)
- metabolic stress (1)
- metabolic syndrome (1)
- metabolischer Stress (1)
- metabolisches Syndrom (1)
- microRNAs (1)
- microarray (1)
- microbiology (1)
- microbiota (1)
- micronutrients (1)
- microvascular complications (1)
- mikrovaskuläre Komplikationen (1)
- mitochondria (1)
- monochlorobenzene (1)
- mucus (1)
- muscle protein turnover (1)
- myocardial infarction (1)
- nephropathy (1)
- networks (1)
- neurons (1)
- neuropathy (1)
- neuropeptides (1)
- nutrients (1)
- offspring (1)
- oxidative stress (1)
- oxidativer Stress (1)
- pathogen (1)
- pflanzliche Sekundär Metabolite (1)
- phenols (1)
- phthalates (1)
- physical activity (1)
- physiology (1)
- plant secondary metabolites (1)
- plastic additives (1)
- poly ungesättigte Fettsäuren (1)
- polyamines (1)
- polytunnel (1)
- polyunsaturated fatty acids (1)
- postprandial response (1)
- preadipocyte (1)
- protected cultivation (1)
- protein interactions (1)
- proteomics (1)
- proteostasis (1)
- pulmonalarterielle glatte Muskelzellen (1)
- pulmonary artery smooth muscle cells (1)
- rat (1)
- refinement (1)
- resistência à insulina (1)
- retinol (1)
- retinopathy (1)
- risk scores (1)
- saline agriculture (1)
- salt taste perception (1)
- sarcopenia (1)
- secondary plant metabolites (1)
- sekundäre Pflanzenstoffe (1)
- selenoneine (1)
- short chain fatty acids (1)
- skeletal muscle (1)
- skeletal muscle aging (1)
- slow and fast fiber types (1)
- smoking (1)
- stroke (1)
- styrene (1)
- sulfide (1)
- systematischer Review (1)
- síndrome metabólica (1)
- trace element (1)
- trans fatty acids (1)
- transcriptomics (1)
- ubiquitin proteasomal system (1)
- verzweigtkettige Aminosäuren (1)
- weight loss (1)
- whey proteins (1)
- whole grains (1)
- whole-grain (1)
- zinc (1)
- Übertragung (1)
Institute
- Institut für Ernährungswissenschaft (114) (remove)
Comparative study of gene expression during the differentiation of white and brown preadipocytes
(2002)
Introduction Mammals have two types of adipose tissue: the lipid storing white adipose tissue and the brown adipose tissue characterised by its capacity for non-shivering thermogenesis. White and brown adipocytes have the same origin in mesodermal stem cells. Yet nothing is known so far about the commitment of precursor cells to the white and brown adipose lineage. Several experimental approaches indicate that they originate from the differentiation of two distinct types of precursor cells, white and brown preadipocytes. Based on this hypothesis, the aim of this study was to analyse the gene expression of white and brown preadipocytes in a systematic approach. Experimental approach The white and brown preadipocytes to compare were obtained from primary cell cultures of preadipocytes from the Djungarian dwarf hamster. Representational difference analysis was used to isolate genes potentially differentially expressed between the two cell types. The thus obtained cDNA libraries were spotted on microarrays for a large scale gene expression analysis in cultured preadipocytes and adipocytes and in tissue samples. Results 4 genes with higher expression in white preadipocytes (3 members of the complement system and a fatty acid desaturase) and 8 with higher expression in brown preadipocytes were identified. From the latter 3 coded for structural proteins (fibronectin, metargidin and a actinin 4), 3 for proteins involved in transcriptional regulation (necdin, vigilin and the small nuclear ribonucleoprotein polypeptide A) and 2 are of unknown function. Cluster analysis was applied to the gene expression data in order to characterise them and led to the identification of four major typical expression profiles: genes up-regulated during differentiation, genes down-regulated during differentiation, genes higher expressed in white preadipocytes and genes higher expressed in brown preadipocytes. Conclusion This study shows that white and brown preadipocytes can be distinguished by different expression levels of several genes. These results draw attention to interesting candidate genes for the determination of white and brown preadipocytes (necdin, vigilin and others) and furthermore indicate that potential importance of several functional groups in the differentiation of white and brown preadipocytes, mainly the complement system and extracellular matrix.
Vitamin E : elucidation of the mechanism of side chain degradation and gene regulatory functions
(2005)
For more than 80 years vitamin E has been in the focus of scientific research. Most of the progress concerning non-antioxidant functions, nevertheless, has only arisen from publications during the last decade. Most recently, the metabolic pathway of vitamin E has been almost completely elucidated. Vitamin E is metabolized by truncation of its side chain. The initial step of an omega-hydroxylation is carried out by cytochromes P450 (CYPs). This was evidenced by the inhibition of the metabolism of alpha-tocopherol by ketoconozole, an inhibitor of CYP3A expression, whereas rifampicin, an inducer of CYP3A expression increased the metabolism of alpha-tocopherol. Although the degradation pathway is identical for all tocopherols and tocotrienols, there is a marked difference in the amount of the release of metabolites from the individual vitamin E forms in cell culture as well as in experimental animals and in humans. Recent findings not only proposed an CYP3A4-mediated degradation of vitamin E but also suggested an induction of the metabolizing enzymes by vitamin E itself. In order to investigate how vitamin E is able to influence the expression of metabolizing enzymes like CYP3A4, a pregnane X receptor (PXR)-based reporter gene assay was chosen. PXR is a nuclear receptor which regulates the transcription of genes, e.g., CYP3A4, by binding to specific DNA response elements. And indeed, as shown here, vitamin E is able to influence the expression of CYP3A via PXR in an in vitro reporter gene assay. Tocotrienols showed the highest activity followed by delta- and alpha-tocopherol. An up-regulation of Cyp3a11 mRNA, the murine homolog of the human CYP3A4, could also be confirmed in an animal experiment. The PXR-mediated change in gene expression displayed the first evidence of a direct transcriptional activity of vitamin E. PXR regulates the expression of genes involved in xenobiotic detoxification, including oxidation, conjugation, and transport. CYP3A, e.g., is involved in the oxidative metabolism of numerous currently used drugs. This opens a discussion of possible side effects of vitamin E, but the extent to which supranutritional doses of vitamin E modulate these pathways in humans has yet to be determined. Additionally, as there is arising evidence that vitamin E's essentiality is more likely to be based on gene regulation than on antioxidant functions, it appeared necessary to further investigate the ability of vitamin E to influence gene expression. Mice were divided in three groups with diets (i) deficient in alpha-tocopherol, (ii) adequate in alpha-tocopherol supply and (iii) with a supranutritional dosage of alpha-tocopherol. After three months, half of each group was supplemented via a gastric tube with a supranutritional dosage of gamma-tocotrienol per day for 7 days. Livers were analyzed for vitamin E content and liver RNA was prepared for hybridization using cDNA array and oligonucleotide array technology. A significant change in gene expression was observed by alpha-tocopherol but not by gamma-tocotrienol and only using the oligonucleotide array but not using the cDNA array. The latter effect is most probably due to the limited number of genes represented on a cDNA array, the lacking gamma-tocotrienol effect is obviously caused by a rapid degradation, which might prevent bioefficacy of gamma-tocotrienol. Alpha-tocopherol changed the expression of various genes. The most striking observation was an up-regulation of genes, which code for proteins involved in synaptic transmitter release and calcium signal transduction. Synapsin, synaptotagmin, synaptophysin, synaptobrevin, RAB3A, complexin 1, Snap25, ionotropic glutamate receptors (alpha 2 and zeta 1) were shown to be up-regulated in the supranutritional group compared to the deficient group. The up-regulation of synaptic genes shown in this work are not only supported by the strong concentration of genes which all are involved in the process of vesicular transport of neurotransmitters, but were also confirmed by a recent publication. However, a confirmation by real time PCR in neuronal tissue like brain is now required to explain the effect of vitamin E on neurological functionality. The change in expression of genes coding for synaptic proteins by vitamin E is of principal interest thus far, since the only human disease directly originating from an inadequate vitamin E status is ataxia with isolated vitamin E deficiency. Therefore, with the results of this work, an explanation for the observed neurological symptoms associated with vitamin E deficiency can be presented for the first time.
Metabolism of the dietary lignan secoisolariciresinol diglucoside by human intestinal bacteria
(2006)
Ontogeny of leptin signalling in the rat hypothalamus: Evidence for selective leptin insensitivity
(2006)
The central melanin-concentrating hormone (MCH) system has been intensively studied for its involvement in the regulation of feeding behaviour and body weight regulation. The importance of the neuropeptide MCH in the control of energy balance has been underlined by MCH knock out and Melanin-concentrating hormone receptor subtype 1 (MCHR-1) knock-out animals. The anorectic and anti-obesity effects of selective MCHR-1 antagonists have confirmed the notion that pharmacological blockade of MCHR-1 is a potential therapeutic approach for obesity. First aim of this work is to study the neurochemical “equipment” of MCHR-1 immunoreactive neurons by double-labelling immunohistochemistry within the rat hypothalamus. Of special interest is the neuroanatomical identification of other hypothalamic neuropeptides that are co-distributed with MCHR-1. A second part of this study deals with the examination of neuronal activation patterns after pharmacological or physiological, feeding-related stimuli and was introduced to further understand central regulatory mechanisms of the MCH system. In the first part of work, I wanted to neurochemically characterize MCHR-1 immunoreactive neurons in the rat hypothalamus for colocalisation with neuropeptides of interest. Therefore I performed an immunohistochemical colocalisation study using a specific antibody against MCHR-1 in combination with antibodies against hypothalamic neuropeptides. I showed that MCHR-1 immunoreactivity (IR) was co-localised with orexin A in the lateral hypothalamus, and with adrenocorticotropic hormone and neuropeptide Y in the arcuate nucleus. Additionally, MCHR-1 IR was co-localised with the neuropeptides vasopressin and oxytocin in magnocellular neurons of the supraoptic and paraventricular hypothalamic nucleus and corticotrophin releasing hormone in the parvocellular division of the paraventricular hypothalamic nucleus. Moreover, for the first time MCHR-1 immunoreactivity was found in both the adenohypophyseal and neurohypophyseal part of the rat pituitary. These results provide the neurochemical basis for previously described potential physiological actions of MCH at its target receptor. In particular, the MCHR-1 may be involved not only in food intake regulation, but also in other physiological actions such as fluid regulation, reproduction and stress response, possibly through here examined neuropeptides. Central activation patterns induced by pharmacological or physiological stimulation can be mapped using c-Fos immunohistochemistry. In the first experimental design, central administration (icv) of MCH in the rat brain resulted in acute and significant increase of food and water intake, but this animal treatment did not induce a specific c-Fos induction pattern in hypothalamic nuclei. In contrast, sub-chronic application of MCHR-1 antagonist promoted a significant decrease in food- and water intake during an eight day treatment period. A qualitative analysis of c-Fos immunohistochemistry of sections derived from MCHR-1 antagonist treated animals showed a specific neuronal activation in the paraventricular nucleus, the supraoptic nucleus and the dorsomedial hypothalamus. These results could be substantiated by quantitative evaluation of an automated, software-supported analysis of the c-Fos signal. Additionally, I examined the activation pattern of rats in a restricted feeding schedule (RFS) to identify pathways involved in hunger and satiety. Animals were trained for 9 days to feed during a three hour period. On the last day, food restricted animals was also allowed to feed for the three hours, while food deprived (FD) animals did not receive food. Mapping of neuronal activation showed a clear difference between stareved (FD) and satiated (FR) rats. FD animals showed significant induction of c-Fos in forebrain regions, several hypothalamic nuclei, amygdaloid thalamus and FR animals in the supraoptic nucleus and the paraventricular nucleus of the hypothalamus, and the nucleus of the solitary tract. In the lateral hypothalamus of FD rats, c-Fos IR showed strong colocalisation for Orexin A, but no co-staining for MCH immunoreactivity. However, a large number of c-Fos IR neurons within activated regions of FD and FR animals was co-localised with MCHR-1 within selected regions. To conclude, the experimental set-up of scheduled feeding can be used to induce a specific hunger or satiety activation pattern within the rat brain. My results show a differential activation by hunger signals of MCH neurons and furthermore, demonstrates that MCHR-1 expressing neurons may be essential parts of downstream processing of physiological feeding/hunger stimuli. In the final part of my work, the relevance of here presented studies is discussed with respect to possible introduction of MCHR-1 antagonists as drug candidates for the treatment of obesity.
Chronic kidney disease and type 2 diabetes mellitus as factors influencing retinol-binding protein 4
(2009)
Dietary antioxidants are believed to play an important role in the prevention and treatment of a variety of diseases associated with oxidative stress. Although there is a wide range of dietary antioxidants, the bulk of the research to date has been focused on the nutrient antioxidants vitamin C, E, and carotenoids. Certain relatively uncommon antioxidants such as lipoic acid (LA), and phenolic compounds such as (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECG), and (-)-epigallocatechin gallate (EGCG), have not been extensively investigated although they may exert greater antioxidant potency than that of carotenoids and vitamins. Extracts from selected plants and plant byproducts may represent rich sources for one or more of such antioxidants and therefore exhibit higher effects than a single antioxidant due to the synergistic effects produced between such antioxidants. However, in the last decade a number of epidemiological, animal and in vitro studies have suggested a protective and therapeutic potency of these antioxidants in a broad range of diseases such as cancer, diabetes, atherosclerosis, cataract and acute and chronic neurological disorders. Inflammation, the response of the host toward any infection or injury, plays a central role in the development of many chronic diseases. Several evidences demonstrated the rise of different types of cancer from sites of inflammation. This suggests that active oxygen species and some cytokines generated in the inflamed tissues can cause injury to DNA and ultimately lead to carcinogenesis. Diethylnitrosamine (DEN) is one of the most important environmental carcinogens, present in a variety of foods, alcoholic beverages, tobacco smoke and it can be synthesized endogenously. In addition to the liver it can induce carcinogenesis in other organs like kidney, trachea, lung, esophagus, fore stomach, and nasal cavity. Several epidemiological and laboratory studies indicate that nitroso compounds including DEN may induce hyperplasia and chronic inflammation which is closely associated with the development of hepatocellular carcinoma. Despite increasing evidence on the potential of antioxidants in modulating the etiology of chronic diseases, little is known about their role in inflammation and acute phase response (APR). Therefore the aim of the present work was to study the protective effect of water and solvent extracts of eight plant and plant byproducts including green tea, artichoke, spinach, broccoli, onion and eggplant, orange and potato peels as well as eight antioxidants agents including EC, EGC, ECG, EGCG, ascorbic acid (AA), acetylcysteine (NAC), α-LA, and alpha-tocopherol (α-TOC) toward acute inflammation induced by interleukin-6 (IL-6) and hepatotoxicity induced by DEN in vitro. The negative acute phase proteins (APP), transthyretin (TTR) and retinol-binding protein (RBP) were used as inflammatory biomarkers analyzed by ELISA, whereas neutral red assay was used for evaluating the cytotoxicity. All experiments were performed in vitro using human hepatocarcinoma cell line (HepG2). Additionally the antioxidant activity was measured by TEAC and FRAP assays, phenolic content was measured by Folin–Ciocalteu and characterized by HPLC. Moreover, the microheterogeneity of TTR was detected using immunoprecipitation assay combined with SELDI-TOF MS. Results of present study showed that HepG2 cells provide a simple, sensitive in vitro system for studying the regulation of the negative APP, TTR and RBP under free and inflammatory condition. IL-6, a potent proinflammatory cytokine, in a concentration of 25 ng/ml was able to reduce TTR and RBP secretion by approximately 50-60% after 24h of incubation. With exception of broccoli and water extract of onion which showed pro-inflammatory effects in this study, all other plant extracts, at specific concentrations, were able to elevate TTR secretion in normal condition and even under treatment of IL-6 where the effect was quite lower. Green tea followed by artichoke and potato peel exhibited the highest elevation in TTR concentration which reached 1.1 and 2.5 folds of control in presence and absences of IL-6 respectively. In general Plant extracts were ordered according their anti-inflammatory potency as following: in water extracts; green tea > artichoke > potato peel > orange peel > spinach > eggplant peel, where in solvent extracts; green tea > artichoke > potato peel > spinach > eggplant peel > onion > orange peel. The antiinflammatory effect of water extracts of green tea, artichoke and orange peel were significantly higher than their corresponding solvent extracts whereas water extracts of eggplant-, potato peels and spinach showed lower effect than their solvent extracts. On the other hand α-LA followed by EGCG and ECG exhibited the highest elevation in TTR concentration compared to other antioxidants. The relation between the anti-inflammatory potential and antioxidants activity and phenolic content for the investigated substances was generally weak. This may suggest the involvement of other mechanisms than antioxidants properties for the observed effect. TTR secreted by HepG2 cells has a molecular structure quite similar to the purified standard and serum TTR in which all the three main variants are contained including native, S-cystinylated and Sglutathionylated TTR. Interestingly, a variant with molecular mass of 13453.8 + 8.3 Da has been detected only in TTR secreted by HepG2. Among all investigated antioxidants and plant extracts, six substances were able to elevate the native preferable TTR variant. The potency of these substances can be ordered as following α-LA > NAC > onion > AA > EGCG > green tea. A weak correlation between elevation on TTR and shifting to the native form was observed. Similar weak correlation has also been observed between antioxidants activity and elevation in native TTR. Although DEN was able to induce cell death in a concentration dependent manner, it requires considerably higher concentrations for its effects especially after 24h. This may be attributed to a lack in cytochrome P450 enzymes produced by HepG2. At selected concentrations some antioxidants and plant extracts significantly attenuate DEN cytotoxicity as following: spinach > α-LA > artichoke > orange peel > eggplant peel > α-TOC > onion > AA. Contrary all other substances especially green tea, broccoli, potato peel, and ECG stimulate DEN toxicity. In conclusion, this study demonstrated that selected antioxidants and plant extracts may attenuate the inflammatory process, not only by their antioxidants potency but also by other mechanisms which remain unclear. They may also play a vital role on stabilizing the tetramic structure of TTR and thereby prevent amyloidosis diseases. Lipoic acid represents in this study unique function against inflammation and hepatotoxicity. Despite the protective effect demonstrated by investigated substances, attention should also be given to the pro-oxidant and potential cytotoxic effects produced at higher concentrations.
The fat-soluble vitamin A, which is chemically referred to retinol (ROH), is known to be essential for the process of vision, the immune system but also for cell differentiation and proliferation. Recently, ROH itself has been reported to be involved in adipogenesis and a ROH transport protein, the retinol-binding protein 4 (RBP4), in insulin resistance and type 2 diabetes. However, there is still considerable scientific debate about this relation. With the increasing amount of studies investigating the relation of ROH in obesity and type 2 diabetes, basic research is an essential prerequisite for interpreting these results. This thesis enhances the knowledge on this relation by reviewing ROH metabolism on extra- and intracellular level. Aim 1: In the blood stream ROH is transported in a complex with RBP4 and a second protein, transthyretin (TTR), to the target cells. The levels of RBP4 and TTR are influenced by several factors but mainly by liver and kidney function. The reason for that is that liver and the kidneys are the sites of RBP4 synthesis and catabolism, respectively. Interestingly, obesity and type 2 diabetes involve disorders of the liver and the kidneys. Therefore the aim was to investigate factors that influence RBP4 and TTR levels in relation to obesity and type 2 diabetes (Part 1). Aim 2: Once arrived in the target cell ROH is bound to cellular retinol-binding protein type I (CRBP-I) and metabolised: ROH can either be stored as retinylesters or it can be oxidised to retinoic acid (RA). By acting as a transcription factor in the nucleus RA may influence processes such as adipogenesis. Therefore vitamin A has been postulated to be involved in obesity and type 2 diabetes. CRBP-I is known to mediate the storage of ROH in the liver, but the extra-hepatic metabolism and the functions of CRBP-I are not well known. This has been investigated in Part 2 of this work. Material & Methods: RBP4 and TTR levels were investigated by ELISA in serum samples of human subjects with overweight, type 2 diabetes, kidney or liver dysfunction. Molecular alterations of the RBP4 and TTR protein structure were analysed by MALDI-TOF mass spectrometry. The functions of intracellular CRBP-I were investigated in CRBP-I knock-out mice in liver and extra-hepatic tissues by measuring ROH levels as well as the levels of its storage form, the retinylesters, using reverse phase HPLC. The postprandial uptake of ROH into tissues was analysed using labelled ROH. The mRNA levels of enzymes that metabolize ROH were examined by real-time polymerase chain reaction (RCR). Results: The previous published results showing increased RBP4 levels in type 2 diabetic patients could not be confirmed in this work. However, it could be shown that during kidney dysfunction RBP4 levels are increased and that RBP4 and TTR levels are decreased during liver dysfunction. The important new finding of this work is that increased RBP4 levels in type 2 diabetic mice were increased when kidney function was decreased. Thus an increase in RBP4 levels in type 2 diabetes may be the effect of a reduced kidney function which is common in type 2 diabetes. Interestingly, during severe kidney dysfunction the molecular structure of RBP4 and TTR was altered in a specific manner which was not the case during liver diseases and type 2 diabetes. This underlines the important function of the kidneys in RBP4 metabolism. CRBP-I has been confirmed to be responsible for the ROH storage in the liver since CRBP-I knock-out mice had decreased ROH and retinylesters (the storage form of ROH) levels in the liver. Interestingly, in the adipose tissue (the second largest ROH storage tissue in the body) ROH and retinylesters levels were higher in the CRBP-I knock-out compared to the wild-type mice. It could be shown in this work that a different ROH binding protein, cellular retinol-binding protein type III, is upregulated in CRBP-I knock-out mice. Moreover enzymes were identified which mediate very efficiently ROH esterification in the adipose tissue of the knock-out mice. In the pancreas there was a higher postprandial ROH uptake in the CRBP-I knock-out compard to wild-type mice. Even under a vitamin A deficient diet the knock-out animals had ROH and retinylesters levels which were comparable to wild-type animals. These results underline the important role of ROH for insulin secretion in the pancreas. Summing up, there is evidence that RBP4 levels are more determined by kidney function than by type 2 diabetes and that specific molecular modifications occur during kidney dysfunction. The results in adipose tissue and pancreas of CRBP-I knock-out mice support the hypothesis that ROH plays an important role in glucose and lipid metabolism.
Ghrelin is a unique hunger-inducing stomach-borne hormone. It activates orexigenic circuits in the central nervous system (CNS) when acylated with a fatty acid residue by the Ghrelin O-acyltransferase (GOAT). Soon after the discovery of ghrelin a theoretical model emerged which suggests that the gastric peptide ghrelin is the first “meal initiation molecule